ONO PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,245 JPY | -1.32% |
|
+2.14% | -10.77% |
| Apr. 30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
| Apr. 29 | US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week | MT |
Chart calendar Ono Pharmaceutical Co., Ltd.
274a.IwStDSpXbra_MzL1xJfndmcvzLFGjtJlXzt0wxzxi0w.E2fhQ1o5V-bqe3eP_dbXEFFKlN4e1LECCF0lgEm7uhZySMFEaBk0zvBpAg~2b3ee5f3872a35276fd82f24c8b79b2e
Upcoming events on Ono Pharmaceutical Co., Ltd.
Past events on Ono Pharmaceutical Co., Ltd.
| 2024-05-08 | Q4 2023 Earnings Release |
| 2024-03-27 | Final dividend |
| 2024-03-26 03:00 am | Investor Meeting - ESG Meeting |
| 2024-02-21 | R&D Day |
| 2024-01-30 | Q3 2023 Earnings Call |
| 2024-01-30 | Q3 2023 Earnings Release |
| 2023-11-01 | Q2 2023 Earnings Call |
| 2023-10-31 | Q2 2023 Earnings Release |
| 2023-09-27 | Ex-dividend day for dividende intermédiaire |
| 2023-07-30 | Q1 2023 Earnings Call |
| 2023-07-30 | Q1 2023 Earnings Release |
| 2023-05-09 | Q4 2022 Earnings Release |
| 2023-03-29 | Ex-dividend day for final dividend |
| 2023-01-30 10:00 pm | Q3 2022 Earnings Release |
| 2022-10-30 | Interim 2022 Earnings Release |
| 2022-09-28 | Ex-dividend day for dividende intermédiaire |
| 2022-07-31 | Q1 2022 Earnings Release |
| 2022-05-10 | FY 2021 Earnings Call |
| 2022-05-10 | FY 2021 Earnings Release |
| 2022-03-29 | Ex-dividend day for final dividend |
Past dividends on Ono Pharmaceutical Co., Ltd.
| 2024-03-27 | Final Payment 40 JPY |
| 2023-09-27 | Interim Payment 40 JPY |
| 2023-03-29 | Final Payment 37 JPY |
| 2022-09-28 | Interim Payment 33 JPY |
| 2022-03-29 | Final Payment 28 JPY |
| 2021-09-28 | Interim Payment 28 JPY |
| 2021-03-29 | Final Payment 27.5 JPY |
| 2020-09-28 | Interim Payment 22.5 JPY |
| 2020-03-29 | Final Payment 22.5 JPY |
| 2019-09-26 | Interim Payment 22.5 JPY |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 288 634 286 281 0.82% | 292 420 296 741 -1.46% | 309 284 312 675 -1.08% | 361 361 364 414 -0.84% | 447 187 447 361 -0.04% | 502 672 508 509 -1.15% |
|
EBITDA Million JPY | Released Forecast Spread | 72 631 76 760 -5.38% | 91 705 87 255 5.1% | 114 150 112 928 1.08% | 120 916 128 255 -5.72% | 159 414 170 966 -6.76% | 178 075 190 285 -6.42% |
|
EBIT Million JPY | Released Forecast Spread | 62 010 64 326 -3.6% | 77 491 74 931 3.42% | 98 330 97 266 1.09% | 103 195 111 308 -7.29% | 141 963 153 846 -7.72% | 159 935 172 026 -7.03% |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 65 141 67 957 -4.14% | 79 696 76 997 3.51% | 100 890 98 881 2.03% | 105 025 112 920 -6.99% | 143 532 156 101 -8.05% | 163 734 174 278 -6.05% |
|
Net income Million JPY | Released Forecast Spread | 51 539 52 945 -2.66% | 59 704 58 378 2.27% | 75 425 75 339 0.11% | 80 519 86 027 -6.4% | 112 723 118 515 -4.89% | 127 977 131 657 -2.8% |
|
EPS JPY | Released Forecast Spread | 100 103 -2.38% | 118 115 2.67% | 151 151 0.15% | 162 173 -6.35% | 231 242 -4.57% | 267 275 -2.96% |
| Announcement Date | 09/05/19 | 12/05/20 | 11/05/21 | 11/05/22 | 10/05/23 | 09/05/24 |
Quarterly results
| Fiscal Period | March | 2020 S1 | 2020 S2 | 2021 S1 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 149 008 144 500 3.12% | 143 412 148 291 -3.29% | 150 474 148 500 1.33% | 174 077 166 700 4.43% | 97 353 93 933 3.64% | 89 931 93 093 -3.4% | 106 722 106 850 -0.12% | 109 979 112 439 -2.19% | 216 701 215 000 0.79% | 122 319 120 350 1.64% | 108 167 111 740 -3.2% | 120 016 117 400 2.23% | 138 697 123 854 11.98% | 258 713 243 971 6.04% | 131 190 161 700 -18.87% | 112 769 123 574 -8.74% | 111 695 | 112 667 | 227 647 | 132 200 | 111 733 |
|
EBITDA Million JPY | Released Forecast Spread | 51 933 69 700 -25.49% | 20 020 51 450 -61.09% | 33 150 | 24 550 | 44 450 | 22 550 | |||||||||||||||
|
EBIT Million JPY | Released Forecast Spread | 41 878 29 600 41.48% | 35 613 32 551 9.41% | 52 401 39 700 31.99% | 58 171 54 150 7.43% | 23 996 27 733 -13.48% | 21 028 28 322 -25.75% | 38 162 41 275 -7.54% | 42 108 43 619 -3.46% | 80 270 77 000 4.25% | 42 320 43 750 -3.27% | 19 373 24 147 -19.77% | 41 348 41 567 -0.53% | 55 688 46 377 20.08% | 97 036 88 101 10.14% | 47 590 45 495 4.6% | 15 309 31 005 -50.62% | 33 112 | 30 133 | 67 153 | 37 067 | 22 733 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 43 042 31 100 38.4% | 36 654 34 229 7.08% | 53 674 41 000 30.91% | 59 231 56 600 4.65% | 25 118 | 20 676 26 736 -22.66% | 39 041 39 200 -0.41% | 41 978 42 738 -1.78% | 81 019 78 200 3.6% | 43 360 42 800 1.31% | 19 153 29 393 -34.84% | 42 378 45 400 -6.66% | 56 918 45 989 23.77% | 99 296 89 151 11.38% | 47 996 36 141 32.8% | 16 442 24 254 -32.21% | 33 366 | 30 800 | 67 538 | 29 700 | 30 200 |
|
Net income Million JPY | Released Forecast Spread | 32 816 23 700 38.46% | 26 888 25 485 5.51% | 39 849 30 600 30.23% | 46 290 43 500 6.41% | 18 330 | 15 899 19 801 -19.7% | 29 477 29 885 -1.37% | 32 862 32 088 2.41% | 62 339 60 100 3.73% | 33 317 32 140 3.66% | 17 067 22 223 -23.2% | 31 818 35 100 -9.35% | 42 673 34 339 24.27% | 74 491 67 225 10.81% | 36 053 34 027 5.95% | 17 433 25 519 -31.69% | 24 113 | 19 300 | 51 624 | 25 450 | 18 150 |
|
EPS JPY | Released Forecast Spread | 64,6 47,5 35.96% | 79,8 61,3 30.24% | 92,7 87,1 6.48% | 36,9 40,0 -7.71% | 32,6 43,9 -25.74% | 60,4 64,9 -6.93% | 67,3 65,7 2.5% | 128 124 2.79% | 68,2 67,4 1.22% | 35,0 44,0 -20.6% | 65,2 69,8 -6.68% | 88,2 96,4 -8.5% | 153 165 -7.24% | 75,8 70,4 7.63% | 37,5 52,0 -27.8% | 61,8 | 66,8 | 121 | 70,5 | 33,8 | |
| Announcement Date | 31/10/19 | 12/05/20 | 29/10/20 | 01/11/21 | 31/01/22 | 11/05/22 | 01/08/22 | 31/10/22 | 31/10/22 | 31/01/23 | 10/05/23 | 31/07/23 | 01/11/23 | 01/11/23 | 31/01/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for Ono Pharmaceutical Co., Ltd.
| 2024-05-28 11:53 am | WOCKHARDT LIMITED: Q4 2024 Earnings Release |
| 2024-05-24 10:54 am | GLENMARK PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-22 05:35 am | SUN PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release |
| 2024-05-22 04:13 am | STRIDES PHARMA SCIENCE LIMITED: Q4 2024 Earnings Release |
| 2024-05-19 02:46 am | MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY: Q1 2024 Earnings Release |
| 2024-05-17 06:10 am | ZYDUS LIFESCIENCES LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 04:25 am | CAPLIN POINT LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 02:15 am | KRKA, D. D.: Q1 2024 Earnings Release |
| 2024-05-15 | CELLTRION PHARM, INC.: Q1 2024 Earnings Release |
| 2024-05-15 | CHONG KUN DANG PHARMACEUTICAL CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4528 Stock
- Calendar Ono Pharmaceutical Co., Ltd.
